Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
ARUP Laboratories, |
RCV001810854 | SCV000605521 | benign | not provided | 2022-08-19 | criteria provided, single submitter | clinical testing | |
Centogene AG - |
RCV000999557 | SCV001426571 | likely pathogenic | Gilbert syndrome | criteria provided, single submitter | clinical testing | ||
Ce |
RCV001810854 | SCV004153499 | benign | not provided | 2024-12-01 | criteria provided, single submitter | clinical testing | UGT1A10: BS1, BS2; UGT1A3: BS1, BS2; UGT1A4: BS1, BS2; UGT1A5: BS1, BS2; UGT1A6: BS1, BS2; UGT1A7: BS1, BS2; UGT1A8: BS1, BS2; UGT1A9: BS1, BS2 |
Pediatric/Medical Genetics, |
RCV003883117 | SCV004697479 | uncertain significance | Crigler-Najjar syndrome type 1; Lucey-Driscoll syndrome; Crigler-Najjar syndrome, type II | criteria provided, single submitter | clinical testing | ||
Institute of Human Genetics, |
RCV000999557 | SCV005368256 | pathogenic | Gilbert syndrome | 2022-08-12 | criteria provided, single submitter | clinical testing | Criteria applied: PS3,PS4,PM3 |
Department of Pathology and Laboratory Medicine, |
RCV005357115 | SCV005919013 | pathogenic | UGT1A8-related condition | 2023-07-07 | criteria provided, single submitter | research | |
OMIM | RCV000013082 | SCV000033328 | risk factor | Gilbert syndrome, susceptibility to | 2004-11-01 | no assertion criteria provided | literature only | |
Difficult and Complicated Liver Diseases and Artificial Liver Center, |
RCV000999557 | SCV001156250 | pathogenic | Gilbert syndrome | 2019-05-01 | no assertion criteria provided | case-control | |
Prevention |
RCV003914830 | SCV004733559 | benign | UGT1A9-related disorder | 2023-01-16 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |